NCT07218146Phase 3Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Study sponsor: Zai Lab (Shanghai) Co., Ltd.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-06-30Estimated
Enrollment · participants480Estimated
Source updated2026-10-16Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Planned enrollment decreased by 185 participants

Before: 665 participants (planned). After: 480 participants (planned).

Primary completion date changed

Before: 30 Nov 2028. After: 30 Jun 2028.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source